Timothy Eugene Sullivan Apellis Pharmaceuticals, Inc. (APLS) insider trading activity

Timothy Eugene Sullivan is Chief Financial Officer of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 79,174 shares of APLS, which is worth approximately $2.17 Million. The most recent transaction as insider was on Feb 10, 2022, when has been sold 875 shares (Common Stock) at a price of $47.12 per share, resulting in proceeds of $41,230. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 79.2K

0% 3M change

1.88% 12M change

Total Value Held $2.17 Million

Timothy Eugene Sullivan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 10 2022	SELL Payment of exercise price or tax liability	$41,230 $47.12 p/Share	875 Reduced 0.84%	103,403 Common Stock
Jan 28 2022	SELL Payment of exercise price or tax liability	$25,084 $38.59 p/Share	650 Reduced 0.62%	104,278 Common Stock
Jan 21 2022	BUY Grant, award, or other acquisition	-	30,787 Added 22.69%	104,928 Common Stock
Jun 08 2021	BUY Exercise of conversion of derivative security	$399,996 $10.03 p/Share	39,880 Added 34.98%	74,141 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$40,944 $47.72 p/Share	858 Reduced 2.44%	34,261 Common Stock
Jan 28 2021	BUY Grant, award, or other acquisition	-	11,250 Added 24.26%	35,119 Common Stock

TES

Timothy Eugene Sullivan

Chief Financial Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Value

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Apellis Pharmaceuticals, Inc.

Track Activities on APLS

Account